Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

63.86
Delayed Data
As of Oct 20
 -0.15 / -0.23%
Today’s Change
45.31
Today|||52-Week Range
75.36
+21.02%
Year-to-Date
Cancer Space Update: Lung & Breast Cancer Studies in Focus
Oct 13 / Zacks.com - Paid Partner Content
Seattle Genetics Begins Phase II Study of Cancer Candidate
Oct 11 / Zacks.com - Paid Partner Content
Seattle Genetics Inks Clinical Collaborations for Cancer Drug
Oct 12 / Zacks.com - Paid Partner Content
Cancer Space Last Week Update: Pipeline Expansion in Focus
Oct 09 / Zacks.com - Paid Partner Content